The global neurovascular devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of neurological disorders and rising demand for minimally invasive procedures. The major players in the global neurovascular devices market are Boston Scientific Corporation, Abbott Laboratories, Medtronic plc., Stryker Corporation, Terumo Corporation and others.
-The Neurovascular Devices market is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The Neurovascular Devices market is driven by the increasing prevalence of neurological disorders, such as stroke and Alzheimer's disease, which are leading to an increased demand for neurovascular devices.
-Increasing incidence rates of neurological disorders are also driving the growth of the Neurovascular Devices market. For instance, in 2016, there were approximately 6 million new cases of dementia worldwide and this number is expected to increase by more than 50% by 2030. The global prevalence rate for dementia was estimated at 4% in 2010 and it is projected that it will reach 7% in 2030. This increase in incidence rates will lead to an increased demand for neurovascular devices over the forecast period (2017 - 2022).
-In addition, technological advancements have led to improved design and performance features that have made these devices more effective than ever before. These factors are also driving the growth of this market over the forecast period (2017 - 2022).
Industry Growth Insights published a new data on “Neurovascular Devices Market”. The research report is titled “Neurovascular Devices Market research by Types (Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices), By Applications (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis), By Players/Companies Stryker Corporation, Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, Acandis”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurovascular Devices Market Research Report
By Type
Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices
By Application
Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis
By Companies
Stryker Corporation, Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, Acandis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Neurovascular Devices Market Report Segments:
The global Neurovascular Devices market is segmented on the basis of:
Types
Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker Corporation
- Medtronic
- Johnson & Johnson
- Terumo Corporation
- Penumbra
- Integer Holdings Corporation
- Microport Scientific Corporation
- Merit Medical Systems
- W.L. Gore & Associates
- Acandis
Highlights of The Neurovascular Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Embolization Devices
- Revascularization Devices
- Accessory Devices
- Thrombectomy Devices
- Embolic Protection Devices
- By Application:
- Aneurysm
- Arteriovenous Malformation and Fistulas (AVM)
- Ischemic Stroke
- Stenosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurovascular Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neurovascular devices are medical devices that are used to treat conditions that affect the blood vessels in the brain and spinal cord. These devices can help improve blood flow to these areas, which can help reduce or prevent damage from occurring.
Some of the major companies in the neurovascular devices market are Stryker Corporation, Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, Acandis.
The neurovascular devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurovascular Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurovascular Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurovascular Devices Market - Supply Chain
4.5. Global Neurovascular Devices Market Forecast
4.5.1. Neurovascular Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurovascular Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurovascular Devices Market Absolute $ Opportunity
5. Global Neurovascular Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurovascular Devices Market Size and Volume Forecast by Type
5.3.1. Embolization Devices
5.3.2. Revascularization Devices
5.3.3. Accessory Devices
5.3.4. Thrombectomy Devices
5.3.5. Embolic Protection Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurovascular Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurovascular Devices Market Size and Volume Forecast by Application
6.3.1. Aneurysm
6.3.2. Arteriovenous Malformation and Fistulas (AVM)
6.3.3. Ischemic Stroke
6.3.4. Stenosis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurovascular Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurovascular Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurovascular Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurovascular Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurovascular Devices Demand Share Forecast, 2019-2029
9. North America Neurovascular Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurovascular Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurovascular Devices Market Size and Volume Forecast by Application
9.4.1. Aneurysm
9.4.2. Arteriovenous Malformation and Fistulas (AVM)
9.4.3. Ischemic Stroke
9.4.4. Stenosis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurovascular Devices Market Size and Volume Forecast by Type
9.7.1. Embolization Devices
9.7.2. Revascularization Devices
9.7.3. Accessory Devices
9.7.4. Thrombectomy Devices
9.7.5. Embolic Protection Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurovascular Devices Demand Share Forecast, 2019-2029
10. Latin America Neurovascular Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurovascular Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurovascular Devices Market Size and Volume Forecast by Application
10.4.1. Aneurysm
10.4.2. Arteriovenous Malformation and Fistulas (AVM)
10.4.3. Ischemic Stroke
10.4.4. Stenosis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurovascular Devices Market Size and Volume Forecast by Type
10.7.1. Embolization Devices
10.7.2. Revascularization Devices
10.7.3. Accessory Devices
10.7.4. Thrombectomy Devices
10.7.5. Embolic Protection Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurovascular Devices Demand Share Forecast, 2019-2029
11. Europe Neurovascular Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurovascular Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurovascular Devices Market Size and Volume Forecast by Application
11.4.1. Aneurysm
11.4.2. Arteriovenous Malformation and Fistulas (AVM)
11.4.3. Ischemic Stroke
11.4.4. Stenosis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurovascular Devices Market Size and Volume Forecast by Type
11.7.1. Embolization Devices
11.7.2. Revascularization Devices
11.7.3. Accessory Devices
11.7.4. Thrombectoy Devices
11.7.5. Embolic Protection Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurovascular Devices Demand Share, 2019-2029
12. Asia Pacific Neurovascular Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurovascular Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurovascular Devices Market Size and Volume Forecast by Application
12.4.1. Aneurysm
12.4.2. Arteriovenous Malformation and Fistulas (AVM)
12.4.3. Ischemic Stroke
12.4.4. Stenosis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurovascular Devices Market Size and Volume Forecast by Type
12.7.1. Embolization Devices
12.7.2. Revascularization Devices
12.7.3. Accessory Devices
12.7.4. Thrombectomy Devices
12.7.5. Embolic Protection Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurovascular Devices Demand Share, 2019-2029
13. Middle East & Africa Neurovascular Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurovascular Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurovascular Devices Market Size and Volume Forecast by Application
13.4.1. Aneurysm
13.4.2. Arteriovenous Malformation and Fistulas (AVM)
13.4.3. Ischemic Stroke
13.4.4. Stenosis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurovascular Devices Market Size and Volume Forecast by Type
13.7.1. Embolization Devices
13.7.2. Revascularization Devices
13.7.3. Accessory Devices
13.7.4. Thrombectomy Devices
13.7.5. Embolic Protection Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurovascular Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Neurovascular Devices Market: Market Share Analysis
14.2. Neurovascular Devices Distributors and Customers
14.3. Neurovascular Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stryker Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Terumo Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Penumbra
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Integer Holdings Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Microport Scientific Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merit Medical Systems
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. W.L. Gore & Associates
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Acandis
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
